4th Microbiome Movement - Drug Development Summit

Evvnt Promotion / evvnt
Archivio
-
26.06.2019 - 28.06.2019  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, USA
Time: 8:30 am to 5:00 pm
 
Temi della conferenza
Pursuing Disease Causation to Foster the Creation of Targeted Microbiome-Based Therapeutics, Biomarkers & Diagnostics

The study of the human microbiome remains one of the most exciting frontiers in modern medicine, that, if targeted correctly, has the potential to benefit millions of patients suffering from numerous diseases. However, the potential for effective disease treatment through the microbiome is matched by the unique challenges in developing them.
Professional congress organizer (PCO)
Microbiome Movement
Annotazioni
Speakers: Bernat Olle, CEO, Vedanta Biosciences, Dan Knights, CEO, CoreBiome, Esi Lamouse-Smith, Director, Janssen Pharmaceuticals, Liz Shepherd, Co-Founder, Novome Biotechnologies, Matthew Henn, EVP Microbiome R&D, Seres Therapeutics, Mike Romanos,
 

Informazioni ed Iscrizioni:

Tickets: https://go.evvnt.com/354252-2?pid=4832
Mr. Jenna Warren
 
Categorie
Medicina General, Medicina interna
Lingua
Inglese
Quote del Congresso
USD 2.799,00
(USD 2799.0 - USD 5198.0)
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Alumni Club Medizinische Universität WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Swiss Tropical and Public Health InstituteCharité International AcademyHilfswerk AustriaCenter of ExcellenceAMREF - African Medical and Research Foundation